期刊文献+

EFFECT OF ARSENIC TRIOXIDE OR ATRA ON PRIMARY APL CELL OR HL-60 CELLS AND THEIR VALUE ANALYSIS IN HYPERLEUKOCYTOSIS

EFFECT OF ARSENIC TRIOXIDE OR ATRA ON PRIMARY APL CELL OR HL-60 CELLS AND THEIR VALUE ANALYSIS IN HYPERLEUKOCYTOSIS
下载PDF
导出
摘要 Objective: To detect the effect of arsenic trioxide or ATRA on APL cells or HL-60 cells and to investigate the mechanism of the hyperleukocytosis and detect the cross resistance between ATRA and arsenic trioxide. Methods: The number of promyelocytes or more matured granulocytes were counted by regular method, MTT test was used to measure the proliferation of HL-60 cells or APL cells, flow cytometry analysis to measure the apoptosis, NBT method to detect the differentiation of HL-60 cells or APL cells. Results: The proliferation of primary APL cells or HL-60 cells could be inhibited in vitro by either arsenic trioxide or ATRA, which could induce obvious apoptosis or obvious differentiation of primary APL cells or HL-60 cells. Inhibition of proliferation or apoptosis of ATRA resistant HL-60 cells were achieved by exposure to arsenic trioxide in vitro. On the other hand, the results of in vivo treatment showed that arsenic trioxide also induce of hyperleukocytosis. Conclusion: The results indicated that the hyperleukocytosis induced by ATRA is not contributed to the mechanism of more differentiation than apoptosis, there was not cross resistance between ATRA and arsenic trioxide. Objective: To detect the effect of arsenic trioxide or ATRA on APL cells or HL-60 cells and to investigate the mechanism of the hyperleukocytosis and detect the cross resistance between ATRA and arsenic trioxide. Methods: The number of promyelocytes or more matured granulocytes were counted by regular method, MTT test was used to measure the proliferation of HL-60 cells or APL cells, flow cytometry analysis to measure the apoptosis, NBT method to detect the differentiation of HL-60 cells or APL cells. Results: The proliferation of primary APL cells or HL-60 cells could be inhibited in vitro by either arsenic trioxide or ATRA, which could induce obvious apoptosis or obvious differentiation of primary APL cells or HL-60 cells. Inhibition of proliferation or apoptosis of ATRA resistant HL-60 cells were achieved by exposure to arsenic trioxide in vitro. On the other hand, the results of in vivo treatment showed that arsenic trioxide also induce of hyperleukocytosis. Conclusion: The results indicated that the hyperleukocytosis induced by ATRA is not contributed to the mechanism of more differentiation than apoptosis, there was not cross resistance between ATRA and arsenic trioxide.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2001年第2期119-123,共5页 中国癌症研究(英文版)
基金 the National Natural Sciences Foundation of China (No. 39470318) and a grant from Science Committee of Shandong Province (No. 9
关键词 Asenic trioxide APL HYPERLEUKOCYTOSIS Asenic trioxide APL Hyperleukocytosis
  • 相关文献

参考文献3

二级参考文献15

  • 1Degos L,Chomienne C,Daniel MT,et al.Treatment of first relapse in acute promyelocytic leukemia with all-trans retinoic acid. The Lancet . 1990
  • 2FenauxP,Managementofacutepromyelocyticleukemia. EurJHaematol . 1993
  • 3Souza LM,Boone TC,Gabrilove J,et al.Recombinant human granulocyte colony-stimulatingfactor, effects on normal and leukemic myeloid cells. Science . 1987
  • 4Welte K,Bonilla MA,Gillio AP,et al.Recombinanthuman granulocyte colony stimulating factor, effectson hematopoiesis in normal and cyclophosphamidetreated primates. The Journal of Experimental Medicine . 1987
  • 5Sun GL,Oyong RY,Chen SJ,et al.Treatment ofacute promyelocytic leukemia (APL) with all-transtetinoic acid (ATRA): A report of five-yearexperience. Chinese Journal of Oncology . 1993
  • 6Knapp W.lmmunofluorescence and RelatedStaining Techniques. . 1979
  • 7Watari K,Asano S,Shirafuji N,et al.Serumgranulocyte colony-stimulating factor levels inhealthy volunteers and patients with various disordersas estimated by enzyme immunoassay. Blood . 1989
  • 8Saller fors B,Olofsson T.Granulocyte-macrophagecolony-stimulating factor (GM-CSF) in serum duringinduction treatment of acute leukemia. British Journal of Haematology . 1991
  • 9Wadhwa M,Thorpe R,Bird CR,et al.Production ofpolyclonal and monoclonal antibodies to humangranulocyte colony-stimulating factor (G-CSF) anddevelopment of immunoassays. Journal of Immunological Methods . 1990
  • 10Shirafuji N,Asan S,Matsuda S,et al.A new bioassayfor human granulocyte colony-stimulating factor (hGCSF) using murine myeloblastic NFS-60 cells astargets and estimation of its levels in sera fromnormal healthy persons and patients with infectiousand hematological disorders. Experimental Hematology . 1989

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部